Skip to content
Screener

Exelixis EXEL Business Segments — Other segment items

Similar metrics at other companies

Broadridge Financial Solutions logo
BRTotal Reportable Segments — Other segment items
$121.4M+7.5%
Iron Mountain logo
IRMTOTAL REPORTABLE SEGMENTS — Other segment items
$938.34M+13.0%
CNN
CNNETotal Reportable Segments — Other segment items
$17.4M+89.1%
GLW
GLWTotal Reportable Segments — Other segment items
$2.77B+16.4%
RCI Hospitality Holdings logo
RICKReportable Segments Excluding Other — Other segment items
$0-100%
Veradermics logo
MANEReportable Segment — Other segment items
-$2.63M-411%

Other financials

Income statement

See full
Revenue$628.7M+10.6%
Gross profit$608.0M+10.8%
Operating income$248.4M+16.3%
Net income$212.1M+14.7%
EPS (diluted)$0.82+26.2%

Balance sheet

See full
Cash & equivalents$281.4M+71.2%
Total debt$165.9M-7.7%
Total equity$1.8B-9.3%
Total assets$2.5B-6.9%

Cash flow

See full
Operating cash flow$307.7M+528%
CapEx$6.8M+140%
Free cash flow$300.9M+552%

Valuation

See full
Market cap$14.25B+40.4%
Enterprise value$14.14B+39.0%
P/E16.6×-0.3×
P/S5.9×+1.3×

Profitability

See full
Gross margin96.5%-0.1pp
Operating margin39.9%+8.5pp
Net margin35.3%+8.3pp
FCF margin48.1%+14.3pp

Returns & leverage

See full
Return on equity44.4%+15.4pp
Debt / equity0.1×0.0×
Current ratio3.5×-0.1×

Where this comes from

Reported directly by Exelixis in its filing.

Tagged under the XBRL concept us-gaap:SegmentReportingOtherItemAmount.

The source filing: Exelixis’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:13 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q3 2026
Accession
0000939767-26-000098
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Cost of goods sold20,65719,47040,61038,642
Drug discovery18,25221,35737,72839,610
Development150,522134,159286,237287,376
Selling, general, and administrative127,413112,931250,283233,706
Other segment items(1)63,37866,718124,616124,134
Interest income(14,210)(16,789)(30,337)(35,865)
Provision for income taxes50,62845,567107,84891,641
Segment and consolidated net income$212,050$184,848$422,517$344,464

Item 1. Financial Statements.

FAQ

What is Exelixis's business segments — other segment items?
Exelixis (EXEL) reported business segments — other segment items of $63.38M in Q2 2026.
How has Exelixis's business segments — other segment items changed year-over-year?
Exelixis's business segments — other segment items decreased by 5.0% year-over-year, from $66.72M to $63.38M.
What is the long-term trend for Exelixis's business segments — other segment items?
Over 3 years (2022 to 2025), Exelixis's business segments — other segment items has grown at a 12.5% compound annual growth rate (CAGR), from $182.9M to $260.13M.
What does business segments — other segment items mean?
Captures miscellaneous operating expenses or income items specific to the segment that do not fall into core R&D or SG&A categories. This may include legal settlements, restructuring charges, or specific segment-level adjustments.

Ask your AI about Exelixis's business segments — other segment items.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude